Source: Eur Respir J 2012; 40: 806-808



Rating:

Share or cite this content

Citations should be made in the following way:
Blasi F., Reichman L.B., Migliori G.B.. Presenting the European Forum for TB Innovation: innovative thinking in progressing towards TB elimination in Europe},. Eur Respir J 2012; 40: 806-808

Member's Comments

No comment yet.

Related content which might interest you: The ERS European Forum for TB Innovation in Europe: a new way to raise innovation Source: Annual Congress 2013 –PG7 Tuberculosis: innovations in clinical and public health management Year: 2013 TB and MDR/XDR-TB in European Union and European Economic Area countries: managed or mismanaged? Source: Eur Respir J 2012; 39: 619-625 Year: 2012 The European union standards for tuberculosis care: Do they need an update? Source: International Congress 2014 – Tuberculosis: public health and primary prevention Year: 2014 The Tuberculosis Network European Trials Group (TBNET): new directions in the management of tuberculosis Source: Breathe, 13 (3) e65; 10.1183/20734735.005517 Year: 2017 European framework for tuberculosis control and elimination in countries with a low incidence: Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis Source: Eur Respir J 2002; 19: 765-775 Year: 2002 Notified or missed cases? An assessment of successful linkage for referred tuberculosis patients in South India Source: International Congress 2015 – Case series and clinical conundrums in TB Year: 2015 Drug resistance among tuberculosis cases in the European Union and European Economic Area, 2007 to 2012 Source: International Congress 2014 – Tuberculosis: public health and primary prevention Year: 2014 The Tuberculosis Network European Trials group (TBnet) ERS Clinical Research Collaboration: addressing drug-resistant tuberculosis through European cooperation Source: Eur Respir J, 53 (1) 1802089; 10.1183/13993003.02089-2018 Year: 2019 Tuberculosis elimination: theory and practice in Europe Source: Eur Respir J 2014; 43: 1410-1420 Year: 2014 Active case finding of tuberculosis, Tomsk (Russia) Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 The future of asthma research and development: a roadmap from the European Asthma Research and Innovation Partnership (EARIP) Source: Eur Respir J, 49 (5) 1602295; 10.1183/13993003.02295-2016 Year: 2017 Active case finding of tuberculosis in Europe: a Tuberculosis Network European Trials Group (TBNET) survey Source: Eur Respir J 2008; 32: 1023-1030 Year: 2008 Childhood tuberculosis outbreaks in EU/EEA: A systematic review Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations Year: 2013 Health Research collaboration in Europe: an innovative initiative Source: Research Seminar 2013 - ERS Presidential Summit on Research gaps, patient needs and innovative solutions: a forward look on lung health research Year: 2013 Sustainability of Russian GLC approved projects and treatment success rate in Russian MDR-TB cohort 2010 Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2 Year: 2014 Drug resistance among new TB cases in some Russian regions Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children Year: 2015 Answering the research gaps on MDR-TB in Europe: the results of the FP7 - funded TB PAN-NET project Source: Annual Congress 2012 - Fighting MDR- and XDR-TB in Europe: from programme results to research implementation Year: 2012 The ERS European Forum for TB Innovation Source: Annual Congress 2013 –ERS/WHO joint lunchtime session "TB-Forum for innovation" Year: 2013 Steps of bedaquline implementation in Georgia Source: International Congress 2016 – Drug-resistant tuberculosis and experiences with delamanid and bedaquiline Year: 2016